Huang, H., Li, W., Zou, L., Li, Y., Zhu, F., Zhou, K., Liang, Y., Zheng, M., Li, Z., Jing, H., Yang, W., He, P., Ding, K., Li, Y., Zhong, M., Liu, Z., Su, L. (2025). Trial in progress: A phase II, multicentre study to evaluate the efficacy and safety of birelentinib (DZD8586) combination therapy in diffuse large B-cell lymphoma (TAI-SHAN12). Blood. https://doi.org/10.1182/blood-2025-8238